Valid only for patients with commercial insurance. Offer eligible only with valid prescription, has no cash value, and cannot be combined with any free trial, discount, prescription savings card, or other offer. Restrictions: No substitutions are permitted. Patient age or insurance restrictions may apply. Offer user must be at least 18 years of age to use for themselves or on behalf of a minor. residents may use this offer at participating pharmacies and may not redeem this offer at government-subsidized clinics. By using this offer, patient and pharmacist understand and agree to comply with these terms and conditions. This program provides eligible patients with assistance to reduce out-of-pocket costs. Eligible uninsured (cash-paying) patients will receive savings on eligible out-of-pocket costs subject to a maximum benefit limit. Eligible commercially insured patients will pay as little as $0 for their monthly prescription, subject to a maximum benefit limit. TERMS AND CONDITIONS: Offer good for patients who meet eligibility criteria purchasing a 30-, 60-, or 90-day supply. Please call 31 with questions and for full eligibility details. PATIENT INSTRUCTIONS: Present this offer to your pharmacist along with a valid prescription for MOVANTIK ® (naloxegol) Tablets. Please see full Prescribing Information for AJOVY. IndicationĪJOVY is indicated for the preventive treatment of migraine in adults. If a hypersensitivity reaction occurs, consider discontinuing AJOVY and institute appropriate therapy.Īdverse Reactions: The most common adverse reactions in clinical trials (≥5% and greater than placebo) were injection site reactions. Cases of anaphylaxis and angioedema have been reported in the postmarketing setting. Most reactions were reported from within hours to one month after administration. Most reactions were mild to moderate, but some led to discontinuation or required corticosteroid treatment. Hypersensitivity Reactions: Hypersensitivity reactions, including rash, pruritus, drug hypersensitivity, and urticaria were reported with AJOVY in clinical trials. Reactions have included anaphylaxis and angioedema. Visit Patient Services Portal QUICK RESOURCESĬontraindications: AJOVY is contraindicated in patients with serious hypersensitivity to fremanezumab-vfrm or to any of the excipients. If the patient is unable to access the portal, they can call Shared Solutions® at 1-80, Monday–Friday, 8:00 am–4:30 pm CT. They can receive authorization for services, apply for financial assistance, enroll in copay assistance programs, and more. From there, the patient can access a variety of services based on their needs. Please direct your patient to the Patient Services Portal. Visit Patient Services Portal How does my patient apply for the Patient Assistance Program? If approved, the patient will receive AJOVY at no cost from the AssistRx Patient Solutions Pharmacy. Meet the insurance eligibility criteria.Visit Patient Services Portal Common questions about the Patient Assistance Program How does my patient qualify for the Patient Assistance Program? ![]() To begin the process, direct your patients to register for the Patient Services Portal. Patients without insurance who cannot afford their out-of-pocket costs may be eligible for a financial assistance program through our Patient Assistance Program. Or discontinue preventive treatment of migraine because of financial reasons. ![]() Teva’s Shared Solutions® believes that no one should have to switch
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |